Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Thyroid Eye Disease (TED) Monocytes Express a Functional Thyrotropin Receptor and Express Increased IL-6 and IL-8: Possible Mechanistic Implications.
Journal: Ophthalmic plastic and reconstructive surgery
Published: February 13, 2026
The Use of Biologics for Thyroid Eye Disease.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: May 05, 2025
Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease".
Journal: Ophthalmic plastic and reconstructive surgery
Published: January 03, 2025
Clinical and Radiologic Predictors of Response to Teprotumumab: A 3D Volumetric Analysis of 35 Patients.
Journal: Ophthalmic plastic and reconstructive surgery
Published: December 23, 2024
Surgical Timing for Patients With Thyroid Eye Disease Treated With Teprotumumab: A Collaborative Multicenter Study.
Journal: Ophthalmic plastic and reconstructive surgery
Published: December 10, 2024
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cells.
Journal: Frontiers in immunology
Published: August 29, 2024
Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: January 11, 2024
Teprotumumab improves light sensitivity in patients with thyroid eye disease.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: November 24, 2023
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease.
Journal: Ophthalmic plastic and reconstructive surgery
Published: November 16, 2023
Last Updated: 09/26/2026